LIMIT-2(redirected from Leicester Intravenous Magnesium Intervention II Trial)
Conclusion While the findings are controversial, LIMIT-2 data indicate that 24-hour IV magnesium sulfate infusion is associated with a 25% decreased mortality
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
LIMIT-2Cardiology A clinical trial–Leicester Intravenous Magnesium Intervention Trial-2— that evaluated the effect of IV magnesium sulfate
on survivors of acute MI. See Acute myocardial infarction, Magnesium sulfate. Cf ISIS-4.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.